BFH772

DB16035InvestigationalSmall molecule

BFH772 is under investigation in clinical trial NCT01449591 (Safety, Tolerability and Efficacy of BFH772 in Rosacea Patients).

Mechanism: Pharmacologically active on Vascular endothelial growth factor receptor 2
Curator reviewed
Formula / weight: C₂₃H₁₆F₃N₃O₃ · 439.394 g/mol (avg)
Code names: BFH-722 · BFH-772

Resolves to

Compound

Structure

InChIKeyJNLSTLQFDDAULK-UHFFFAOYSA-NSMILESOCC1=CC(OC2=CC3=CC=CC(C(=O)NC4=CC=CC(=C4)C(F)(F)F)=C3C=C2)=NC=N1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2Clinical trialsPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with BFH772, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.